This article provides an overview of the current status of ultrahigh-field 7-T magnetic resonance (MR) imaging in neuro-oncology, specifically for the management of patients with brain tumors. It includes a discussion of areas across the pretherapeutic, peritherapeutic, and posttherapeutic stages of patient care where 7-T MR imaging is currently being exploited and holds promise. This discussion includes existing technical challenges, barriers to clinical integration, as well as our impression of the future role of 7-T MR imaging as a clinical tool in neuro-oncology.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.mric.2020.09.007 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!